Annam Biosciences (Annam), founded in 2012, is an early-stage specialty biotech company focused on developing better targeted therapeutics. Its therapeutics (drugs) are designed with proprietary multimeric specified chemical characteristics to target specific cells and upload a known therapeutic payload (approved drug) at the site of disease to enhance its efficacy while minimizing adverse effects on healthy tissues.